"Updates on Diabetes Management" - C. Rachel Kilpatrick, MD

This talk discusses recent updates in diabetes management, including updated treatment guidelines and goals, emerging medications, and an overview of insulin treatment guidance. 

Speaker bio: Dr. Kilpatrick is a native of Fayetteville, AR and has been in practice there at Washington Regional Hospital for the past 9 years.  She went to medical school at the University of Texas Southwestern Medical School in Dallas after which she went to Washington University in St Louis for residency and fellowship.  She has served as the Vice President of the Washington County Medical Society and is a member of the ADA, AACE, and Endocrine Society.  She also recently started the Arkansas Diabetes and Endocrinology Education Foundation, a nonprofit organization aimed at improving endocrine care and education in the state of Arkansas and is passionate about the care and treatment of patients with diabetes.

At the end of the presentation, attendees should be able to:

1. Describe updates in treatment guidelines for Type 2 Diabetes over the past five years.
2. Summarize the latest research on the cardiovascular benefits of GLP1 Receptor Agonists and SGLT2 inhibitors for patients with diabetes and heart failure, and describe the indications for when to start one of these medications.
3. Discuss indications and considerations for starting insulin in a patient with Type 2 Diabetes

This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 19 AAPA
Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. Approval is valid from 3/8/2024 to
3/8/2025. AAPA reference number: CME-2010808.

The speaker serves on speakers bureau for Sanofi, NovoNordisk, Amgen, Dexcom, and Abbott but did not receive direct compensation from any companies for this talk.